Posts

Posted on

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit

PR Newswire

NEW YORK, Sept. 6, 2026 /PRNewswire/ —

Rosen Law Firm Logo

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June 24, 2026, inclusive (the “Class Period”), of the important October 5, 2026 lead plaintiff deadline.

So what: If you purchased ARS Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the ARS Pharmaceuticals class action, go to https://rosenlegal.com/cases/ars-pharmaceuticals-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 5, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants provided investors with material information concerning ARS Pharmaceuticals’ expected timeline for expanded insurance coverage for its epinephrine nasal spray, neffy, with CVS Caremark. Defendants’ statements included, among other things, confidence that this coverage would begin on July 1, 2026, and be in place for the summer and back-to-school allergy seasons.

According to the lawsuit, defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning the expected timeline for the expanded insurance coverage for neffy through CVS Caremark. This caused shareholders to purchase ARS Pharmaceuticals securities at artificially inflated prices. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the ARS Pharmaceuticals class action, go to https://rosenlegal.com/cases/ars-pharmaceuticals-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/spry-investors-have-opportunity-to-lead-ars-pharmaceuticals-inc-securities-fraud-lawsuit-302870479.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

SMPL Investors Have Opportunity to Lead The Simply Good Foods Company Securities Fraud Lawsuit

PR Newswire

NEW YORK, Sept. 6, 2026 /PRNewswire/ —

Rosen Law Firm Logo

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Simply Good Foods Company (NASDAQ: SMPL) between October 24, 2024 and April 8, 2026, inclusive (the “Class Period”), of the important October 13, 2026 lead plaintiff deadline.

So what: If you purchased Simply Good Foods common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Simply Good Foods class action, go to https://rosenlegal.com/cases/the-simply-good-foods-company/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 13, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) Simply Good Foods had lost key managerial personnel following the acquisition of Only What You Need, Inc. (“OWYN”) necessary for the successful integration of the acquired OWYN assets, impairing Simply Good Foods’ ability to achieve the acquisition’s purported strategic initiatives and financial and operational targets; (2) Simply Good Foods had materially increased its general and administrative spending to compensate for the loss of key managerial personnel, leading to an inefficient and bloated organizational structure and the lack of clear and cohesive strategic priorities for its OWYN segment; (3) the addition of a new pea protein supplier for OWYN formulations prior to the acquisition had created significant product quality issues which had negatively impacted the taste, texture, and shelf-life of OWYN products, leading to negative product reviews, depressed consumer sales, and the loss of important distributor relationships; (4) in an effort to boost sales in the short-term, Simply Good Foods had offered discounts and engaged in other promotional activities for OWYN products above its historical practices, eroding Simply Good Foods’ margins but failing to achieve the desired sales turnaround; (5) in order to stem the margin erosion being suffered in its OWYN segment, Simply Good Foods had cut brand support and marketing for OWYN, further depressing product sales; and (6) as a result of the above, the OWYN acquisition had largely failed to achieve its key strategic goals, the integration of OWYN had run into severe operational and execution problems, and the business and operational results for Simply Good Foods’ OWYN segment had been materially negatively impacted, undermining the acquisition’s economic rationale. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Simply Good Foods class action, go to https://rosenlegal.com/cases/the-simply-good-foods-company/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/smpl-investors-have-opportunity-to-lead-the-simply-good-foods-company-securities-fraud-lawsuit-302870473.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

Papa John’s International, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – PZZA

Papa John’s International, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – PZZA

LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group reminds investors of a class action lawsuit against Papa John’s International, Inc. (“Papa John’s” or “the Company”) (NASDAQ: PZZA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of PZZA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: August 7, 2025 to August 5, 2026

DEADLINE: November 2, 2026

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Papa John’s continued to lose market share as its transformation plan failed to achieve results as quickly as it had planned. The Company used aggressive promotions to protect its market share. Based on these facts, Papa John’s public statements were false and materially misleading throughout the class period.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Posted on

Beta Bionics, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – BBNX

Beta Bionics, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – BBNX

LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group reminds investors of a class action lawsuit against Beta Bionics, Inc. (“Beta Bionics” or “the Company”) (NASDAQ: BBNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of BBNX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: July 30, 2025 to February 24, 2026

DEADLINE: November 3, 2026

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Beta Bionics touted the safety, efficacy, and commercial success of the iLet Bionic Pancreas insulin pump (“iLet”), the Company’s sole commercialized product. After disclosing that the FDA had issued a Form 483 following an inspection of the Company’s manufacturing facility, Defendants repeatedly assured investors that the agency’s observations concerned only the Company’s criteria for deciding which customer complaints were reportable, that they reflected no underlying problem with the device, and that the complaints the Company would now be required to report were minor events of the kind requiring no medical intervention. In truth, the FDA’s findings reached the Company’s quality management system, its investigation and correction of known device malfunctions, and the risk analysis for the device itself, and the events the Company had failed to report included serious injuries. Defendants continued to reassure investors and to characterize the agency’s concerns as procedural even as further information emerged showing that the unreported events were far more serious than Defendants had represented and that the FDA’s objections were not confined to a difference in regulatory interpretation. Based on these facts, Beta Bionics’ public statements were false and materially misleading throughout the class period.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Posted on

Zhihu Inc. Announces Proposed Subscription in AI-Focused Investment Fund

BEIJING, China, Sept. 06, 2026 (GLOBE NEWSWIRE) — Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced that the Company, through a wholly owned subsidiary, has entered into a subscription agreement for a limited partnership interest in Tianjin Lisi Xingshen Equity Investment Partnership (Limited Partnership) (the “Fund”), subject to approval by the Company’s shareholders at an extraordinary general meeting (“EGM”).

The proposed subscription involves a capital commitment of RMB1.5 billion, payable in cash pursuant to the Fund’s capital call arrangements. The Company expects that its interest in the Fund will be no more than 30% immediately following completion of the proposed subscription.

The Fund will primarily invest, directly or indirectly, in early-to-mid-stage unlisted enterprises in the field of AI and related technology sectors established or operating in, or with other significant nexus to, mainland China. The Fund will adopt a blind pool structure, and the Fund’s investment targets have not yet been determined. The Company, as a limited partner, will not participate in the Fund’s day-to-day management or specific investment decisions.

The Company believes that the proposed subscription will enable it to leverage the fund manager’s sector expertise, industry resources and investment capabilities to broaden its access to high-quality AI and technology investment opportunities, deepen its understanding of emerging technologies, products and business models, and explore potential collaboration opportunities across the broader AI ecosystem.

The proposed subscription does not represent a change in the Company’s principal business or strategic focus. Zhihu will continue to focus on the development of its online content community and core businesses, while prudently evaluating AI-related business opportunities and pursuing disciplined capital allocation with a view to creating long-term value for its shareholders.

The proposed subscription constitutes a major transaction under Chapter 14 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and is subject to shareholders’ approval at an EGM that the Company plans to convene in the near future. Further information regarding the proposed subscription is available in the Company’s announcement published on the website of the Hong Kong Stock Exchange on September 6, 2026.

About Zhihu Inc.

Zhihu Inc. (NYSE: ZH; HKEX: 2390) is a leading online content community where people come to find solutions, make decisions, seek inspiration, and have fun. Since the initial launch in 2010, Zhihu has grown into the largest Q&A-inspired online content community in China. For more information, please visit https://ir.zhihu.com.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC and the Hong Kong Stock Exchange. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

For investor and media inquiries, please contact:

Zhihu Inc.

Email: [email protected]

Christensen Advisory

Roger Hu
Tel: +86-10-5900-1548
Email: [email protected]



Posted on

Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call

BASEL, Switzerland and LONDON and NEW YORK, Sept. 06, 2026 (GLOBE NEWSWIRE) — Roivant (Nasdaq: ROIV) and Pulmovant today announced that results from the Phase 2 PHocus study of mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) will be presented at the European Respiratory Society (ERS) International Congress 2026 at 12:15 CEST (6:15 a.m. ET) on Tuesday, September 8, 2026, by Marc Humbert, MD, PhD, Professor of Respiratory Medicine at Université Paris-Saclay and Director of the French National Reference Center for Pulmonary Hypertension. Roivant will also host an investor call and webcast at 8:00 a.m. ET on Tuesday, September 8, 2026.

To access the conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under “Events & Presentations” in the Investors section of the Roivant website at www.investor.roivant.com/news-events/events.  The archived webcast will be available on Roivant’s website after the conference call.

About Roivant

Roivant (Nasdaq: ROIV) is a commercial-stage biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant’s pipeline includes LISRAYA™ (brepocitinib), a potent small molecule inhibitor of JAK1 and TYK2 FDA-approved for the treatment of dermatomyositis in adult patients and also in late-stage development for the treatment of non-infectious uveitis, cutaneous sarcoidosis and lichen planopilaris; IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. We advance our pipeline by creating nimble subsidiaries or “Vants” to develop and commercialize our medicines and technologies. For more information, visit www.roivant.com.

Forward-Looking Statements

This press release contains forward-looking statements. Statements in this press release may include statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are usually identified by the use of words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and variations of such words or similar expressions. The words may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act.

Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future, and statements that are not historical facts, including statements about the clinical and therapeutic potential of our product and product candidates, the availability and success of topline results from our ongoing clinical trials, any commercial potential of our product and product candidates following applicable regulatory approvals and the outcome of any pending litigation. In addition, any statements that refer to projections, forecasts or other characterizations of future events, results or circumstances, including any underlying assumptions, are forward-looking statements. Actual results may differ materially from those contemplated in these statements due to a variety of risks, uncertainties and other factors.

Although we believe that our plans, intentions, expectations and strategies as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a number of risks, uncertainties and assumptions, including, but not limited to, those risks set forth in the Risk Factors section of our filings with the U.S. Securities and Exchange Commission. Moreover, we operate in a very competitive and rapidly changing environment in which new risks emerge from time to time. These forward-looking statements are based upon the current expectations and beliefs of our management as of the date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as required by applicable law, we assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts:

Investors

Keyur Parekh
[email protected] 

Media

Stephanie Lee
[email protected] 



Posted on

PHH, BYAH Deadline: PHH, BYAH Investors with Losses in Excess of $100K Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit

PR Newswire

NEW YORK, Sept. 5, 2026 /PRNewswire/ —

Rosen Law Firm Logo

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”), of the important September 28, 2026 lead plaintiff deadline.

So what: If you purchased Park Ha securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Park Ha class action, go to https://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Park Ha’s business, operations, and the true nature of its securities trading activity. Specifically, defendants failed to disclose that: (1) Park Ha was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) Park Ha’s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price; (3) Park Ha’s IPO was intentionally structured with an extremely low public float to enable the manipulation scheme; and (4) as a result of the foregoing, defendants’ positive statements about Park Ha’s business, operations, and prospects were misleading and/or lacked a reasonable basis.

To join the Park Ha class action, go to https://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/phh-byah-deadline-phh-byah-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-park-ha-biological-technology-co-ltd-securities-lawsuit-302870523.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

Verizon Waives Charges for Hurricane Lowell, Prepares Network in Hawai’i

At a glance

  • Customer relief offer: We are waiving calling, texting and data charges on Kaua’i to help our consumer and small business customers connect with loved ones.
  • Strengthened network infrastructure: We have prepared our Hawai’i network with backup generators, satellite assets, and pre-staged equipment designed for reliability during severe weather.
  • Satellite messaging: Verizon customers can maintain essential communications via satellite, allowing compatible phones to send text messages or connect with emergency services.
  • Proactive collaboration: We are working directly with the Hawai’i Emergency Management Agency (HIEMA), local power providers, and public safety officials to support critical infrastructure.
  • Customer resources: We offer essential digital preparedness steps to help residents and businesses stay connected and secure ahead of the storm.

HONOLULU, Hawaii, Sept. 05, 2026 (GLOBE NEWSWIRE) — As Major Hurricane Lowell approaches Hawai’i, Verizon will waive domestic call, text, and data charges. This relief offer applies through September 14 for prepaid* and postpaid consumer customers as well as small business customers** throughout Kaua’i.

Customers do not have to take any action to take advantage of the offer.

In addition, Verizon has taken proactive, on-the-ground measures across the islands to protect connectivity. The company’s focus: keeping customers, local businesses and public safety partners connected when it matters most.

“We know how stressful it is for the people of Hawaiʻi to brace for yet another storm,” said Aimee Novak, West Area President for Verizon. “Our commitment to this community is enduring and our focus right now is keeping you connected to the people and services that matter most. With Hurricane Lowell approaching, our response teams remain fully activated, and we owe a massive thank you to the local crews working around the clock to support this community once again.”

Verizon’s network preparation strategy for Hawai’i

Verizon’s network infrastructure in Hawai’i is engineered to withstand severe weather. A significant portion is backed by fully refueled permanent site generators providing multiple days of backup power reserves. At sites without permanent generators, we have portable generators and other backup solutions available for deployment. To further reinforce operational resilience against potential disruptions, Verizon engineers have satellite assets available to dispatch as needed.

Verizon is working directly with local power companies, the Hawai’i Emergency Management Agency (HIEMA), and state public safety officials. The company remains on constant standby to safeguard critical communications.

How residents and businesses can prepare now

Hurricane Lowell is the third tropical system this year to threaten the state, but with the size and strength of this storm, it’s especially important residents finalize their personal digital preparedness plans:

  1. Charge devices: Keep all mobile devices, tablets, and portable power banks fully charged well before storm watches or warnings are issued for your location.
  2. Protect your gear: Place phones, chargers, and external batteries in waterproof accessories or heavy-duty zip-lock bags to safeguard them against floodwaters or rain.
  3. Establish a communication plan: Coordinate a dedicated ohana (family) emergency plan and save key emergency contact numbers directly to your devices.
  4. Check on your kūpuna (elders): To ensure their devices are charged and they have an emergency communication plan in place.
  5. Secure visual backups: Take photos of your home, vehicle, and valuables for insurance purposes. Ensure these images are uploaded to the cloud so you can access them even if your phone is lost or damaged.
  6. Utilize digital resources: Download critical weather tracking, news, and American Red Cross safety apps ahead of time.
  7. Mitigate customer disruption: List critical software, equipment, service contracts and vital contacts (utilities, vendors, authorities) needed to maintain operations. Review coverage with your insurance agent to eliminate gaps.
  8. Contacts and documents are key: Centralize updated contact info for all staff (including remote and satellite offices) and keep accessible, secure copies of your insurance policies.
  9. Keep track of equipment: Maintain an inventory of all corporate hardware deployed to remote employees to streamline claims for potential loss or damage.
  10. The right tech makes an impact: Secure the mobile-ready technology and infrastructure needed to maintain business connectivity if you are forced to relocate.
  11. Have a backup plan: Establish a protocol to immediately reroute workloads if remote employees lose power or face evacuation.

Should terrestrial services become unavailable, Verizon encourages customers with compatible satellite-enabled devices (such as iPhone 14 or newer running iOS 18+, or Google Pixel 9 or newer) to test emergency satellite messaging features before the storm begins to cause impacts.

Verizon will continue monitoring Hurricane Lowell and will provide local network status updates as necessary. Customers can track real-time network status using the Check Network Status tool on Verizon’s website or directly within the My Verizon mobile app.


Visit the Emergency Resource Center for further details on Verizon’s emergency response capabilities.

*For Value customers impacted, we are extending the service end dates. This includes customers across Verizon’s value brands, including Straight Talk, Tracfone, Total Wireless, Walmart Family Mobile, Page Plus, Simple Mobile, SafeLink Wireless, and Net10 Wireless.
**Verizon small business customers include customers with 50 lines or less.

This announcement was originally published by Verizon. Read the original press release.

Verizon Communications Inc. (NYSE, Nasdaq: VZ) powers and empowers how its millions of customers live, work and play, delivering on their demand for mobility, reliable network connectivity and security. Headquartered in New York City, serving countries worldwide and nearly all of the Fortune 500, Verizon generated revenues of $138.2 billion in 2025. Verizon’s world-class team never stops innovating to meet customers where they are today and equip them for the needs of tomorrow. For more, visit verizon.com or find a retail location at


verizon.com/stores


.

VERIZON’S ONLINE MEDIA CENTER: News releases, stories, media contacts and other resources are available at verizon.com/news. News releases are also available through an RSS feed. To subscribe, visit www.verizon.com/about/rss-feeds/.

Media contacts: 

Pete Burd
[email protected]

Meagan Dorsch
[email protected]



Posted on

DVLT Investors Have Opportunity to Lead Datavault AI Inc. Securities Fraud Lawsuit

PR Newswire

NEW YORK, Sept. 5, 2026 /PRNewswire/ —

Rosen Law Firm Logo

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Datavault AI Inc. (NASDAQ: DVLT) between September 4, 2024 and October 30, 2025, inclusive (the “Class Period”), of the important October 5, 2026 lead plaintiff deadline.

So what: If you purchased Datavault AI securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Datavault AI class action, go to https://rosenlegal.com/cases/datavault-ai-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 5, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants made materially false and/or misleading statements and or failed to disclose that: (1) defendants had overstated the economic value to Datavault AI of its various corporate partnerships with, inter alia, Burke, Scilex, and Nature’s Miracle; (2) Defendants had overstated the volume of trading activity on the Datavault Platform, which was in fact minimal; (3) Datavault’s undisclosed connections with Edward Withrow III, a convicted felon, when revealed, would cause Datavault AI to incur reputational harm; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times.

To join the Datavault AI class action, go to https://rosenlegal.com/cases/datavault-ai-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dvlt-investors-have-opportunity-to-lead-datavault-ai-inc-securities-fraud-lawsuit-302870468.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

LOS ANGELES–(BUSINESS WIRE)–Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Unicycive Therapeutics, Inc. (“Unicycive” or “the Company”) (NASDAQ: UNCY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of UNCY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: December 29, 2025 to June 29, 2026

DEADLINE: November 2, 2026

If you are a shareholder who suffered a loss, click here to participate.

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Unicycive failed to inspect its third-party manufacturing partner to ensure compliance with good manufacturing practices. The Company had no support for the belief that its vendor resolved deficiencies identified by the FDA. The Company suffered from an undisclosed risk of further scrutiny by the FDA. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Unicycive, investors suffered damages.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Join the case to recover your losses

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Schall, Brown & Schwartz LLP

Brian Schall, Esq.,

Andrew Brown, Esq.,

David Schwartz, Esq.,

www.schallfirm.com

Office: 310-301-3335

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Logo
Logo